Could you expand on these two points? They seem contradictory.
I didn't make the statement, but I do agree with it.
A lot of drug companies sell their products here, but the development/sales are based in another country.
Take VG Health Care (Investor series - VGHCX). It's currently our top performer YTD (+16.44%) and is made up of foreign holdings (19.27%).
An example in heavy industry? Mack Trucks (you know, the one with the bulldog on the front) is owned by Volvo AB in Sweden (not Volvo car - that was spun off years ago, first to Ford (US), and then to a company based in China (Zhejiang Geely Holding Group).
A lot of "products" that have been previously known as "American" (more specifically U.S.) no longer are owned by US based companies. Sure, they may produce products for the US market, but the top management (along with the profits) are offshore.
That's why I/DW invest in funds that contain companies that are international in nature.
I believe the comment was that many folks invest in US companies with foreign exposure but never consider the "other side of the coin" - that is investing in foreign companies with a lot of US exposure.
It's a global marketplace. To insure diversity in investing it's a good idea (IMHO) to "place your bets" across the board - much like roulette.